A new article in JAMA reports self-blood glucose monitoring for type 2 diabetes is not necessary.
Is there an alternative?
December 18, 2018
Leveraging New Technologies for Better Diabetes Care
January 24, 2017
Diabetes Monitoring and Diagnosis Beyond A1c
January 18, 2017
November is American Diabetes Month
November 28, 2016
Epinex Diagnostics Enters Digital Health Field –Launches “Am I Diabetic” Mobile Phone App
November 17, 2016
December 31, 2015
"Sam Finta has always been fit and considered himself healthy. Everything changed with a diagnosis of Type 1 diabetes in 1999."
It's a lifelong disease and you have to manage it several hours a day," Finta said.
But that all changed when he became part of a clinical trial for a powdered form of insulin called Afrezza.
Rather than pumps and injections, the drug comes in a little whistle-like device that is inhaled just before mealtime."
Click here to read the full article
A new utility of glycated albumin in monitoring car...
Epinex’s Research Paper Reaches New Milestone
Epinex at the 2017 AACC Conference
Beyond A1C: Glycated Albumin Takes Center Stage at...
Amidst Healthcare Chaos, California Authorizes a Ne...
A new article in JAMA reports self-blood glucose mo...
Plug and Play Tech Center
Asad Zaidi CEO of Epinex Diagnostic Inc. will atten...
Glycated Albumin used in measuring ‘Stress Diabetes...
A potential role of glycated albumin as a marker fo...